Zhu Genhai

Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial

Shannon N. Westin, Kathleen N. Moore, Hye Sook Chon et al. · Journal of Clinical Oncology · 2023 · 331 citations · Full text

Medicine, Oncology, Pharmacology +12

Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China

Xiaohua Wu, Yang Sun, Hongying Yang et al. · The Lancet · 2024 · 102 citations

Medicine, Oncology, Pharmacology +13

Evaluation of ecosystem health and potential human health hazards in the Hangzhou Bay and Qiantang Estuary region through multiple assessment approaches

Zhu Genhai, Md Abu Noman, Dhiraj Dhondiram Narale et al. · Environmental Pollution · 2020 · 92 citations · Full text

Natural Sciences, Environmental Sciences, Marine Sciences +17

Bioaccumulation and potential human health risks of metals in commercially important fishes and shellfishes from Hangzhou Bay, China

Md Abu Noman, Weihua Feng, Zhu Genhai et al. · Scientific Reports · 2022 · 84 citations · Full text

Veterinary Medicine, Environmental Sciences, Toxicology +17

Effects of fish farming on phytoplankton community under the thermal stress caused by a power plant in a eutrophic, semi-enclosed bay: Induce toxic dinoflagellate (Prorocentrum minimum) blooms in cold seasons

Zhibing Jiang, Yibo Liao, Jingjing Liu et al. · Marine Pollution Bulletin · 2013 · 57 citations

Life Sciences, Ecology, Environmental Sciences +17